Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-11-18
2008-11-04
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S356100, C548S373100, C548S374100, C514S403000
Reexamination Certificate
active
07446121
ABSTRACT:
Novel compounds and pharmaceutical compositions useful as hypocholesterolemic and hypolipidemic agents are described. More specifically, potent inhibitors of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (“HMG CoA reductase”) are described. Methods of using such compounds and compositions to treat subjects, including humans, suffering from hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, atherosclerosis, Alzheimer's Disease, benign prostatic hypertrophy (BPH), diabetes and osteoporosis are also described.
REFERENCES:
patent: 3261859 (1966-07-01), Dengel et al.
patent: 3262977 (1966-07-01), Harsanyi et al.
patent: 3683080 (1972-08-01), Francis
patent: 3752814 (1973-08-01), Fluckiger et al.
patent: 3752888 (1973-08-01), Fluckiger et al.
patent: 3822287 (1974-07-01), Bolger et al.
patent: 3857952 (1974-12-01), Wooldridge et al.
patent: 3932400 (1976-01-01), Hibino et al.
patent: 3962238 (1976-06-01), Mauvernay et al.
patent: 4062950 (1977-12-01), Frommer et al.
patent: 4133814 (1979-01-01), Jones et al.
patent: 4174439 (1979-11-01), Rauenbusch et al.
patent: 4189438 (1980-02-01), Umezawa et al.
patent: 4217305 (1980-08-01), Imai et al.
patent: 4217307 (1980-08-01), Planker et al.
patent: 4242453 (1980-12-01), Umezawa et al.
patent: 4248883 (1981-02-01), Sawayama et al.
patent: 4254256 (1981-03-01), Otani et al.
patent: RE30577 (1981-04-01), Busch et al.
patent: 4273765 (1981-06-01), Suhara et al.
patent: 4405644 (1983-09-01), Kabbe et al.
patent: 4410520 (1983-10-01), Watthey
patent: 4418068 (1983-11-01), Jones
patent: 4451455 (1984-05-01), Vertesy et al.
patent: 4452813 (1984-06-01), Fujii et al.
patent: 4536516 (1985-08-01), Harper et al.
patent: 4567175 (1986-01-01), Takeda et al.
patent: 4572909 (1986-02-01), Campbell et al.
patent: 4598089 (1986-07-01), Hadvary et al.
patent: 4613610 (1986-09-01), Wareing
patent: 4623660 (1986-11-01), Richardson
patent: 4623714 (1986-11-01), Vertesy et al.
patent: 4631286 (1986-12-01), Shutske et al.
patent: 4634765 (1987-01-01), Liu
patent: 4639436 (1987-01-01), Junge et al.
patent: 4663318 (1987-05-01), Davis
patent: 4681893 (1987-07-01), Roth
patent: 4701559 (1987-10-01), Horii et al.
patent: 4766121 (1988-08-01), Ellis et al.
patent: 4816456 (1989-03-01), Summers
patent: 4826876 (1989-05-01), Ellis et al.
patent: 4839155 (1989-06-01), McCague
patent: 4879303 (1989-11-01), Davison et al.
patent: 4895841 (1990-01-01), Sugimoto et al.
patent: 4910305 (1990-03-01), Ellis et al.
patent: 4929629 (1990-05-01), Jeffery
patent: 4948807 (1990-08-01), Rosini et al.
patent: 4957971 (1990-09-01), Picard et al.
patent: 4996225 (1991-02-01), Toivola et al.
patent: 5061798 (1991-10-01), Emmett et al.
patent: 5091524 (1992-02-01), Vertesy et al.
patent: 5155120 (1992-10-01), Lazar et al.
patent: 5157116 (1992-10-01), Ducep et al.
patent: 5185351 (1993-02-01), Finkelstein et al.
patent: 5192772 (1993-03-01), Yoshikuni et al.
patent: 5196444 (1993-03-01), Naka et al.
patent: 5273995 (1993-12-01), Roth
patent: 5274143 (1993-12-01), Ramig et al.
patent: 5284971 (1994-02-01), Walker et al.
patent: 5391571 (1995-02-01), Mewshaw et al.
patent: 5401772 (1995-03-01), Yokoyama et al.
patent: 5420305 (1995-05-01), Ramig et al.
patent: 5484795 (1996-01-01), Bryant et al.
patent: 5488058 (1996-01-01), Palkowitz
patent: 5504078 (1996-04-01), Ducep et al.
patent: 5510379 (1996-04-01), Lee et al.
patent: 5512565 (1996-04-01), Mewshaw et al.
patent: 5540917 (1996-07-01), Isler et al.
patent: 5552412 (1996-09-01), Cameron et al.
patent: 5569674 (1996-10-01), Yokoyama et al.
patent: 5602151 (1997-02-01), Mewshaw et al.
patent: 5643874 (1997-07-01), Bremer et al.
patent: 5654468 (1997-08-01), Yokoyama et al.
patent: 5728704 (1998-03-01), Mylari et al.
patent: 5861385 (1999-01-01), Angerbauer et al.
patent: 5866578 (1999-02-01), Mylari et al.
patent: 5969156 (1999-10-01), Briggs et al.
patent: 5985864 (1999-11-01), Imai et al.
patent: 6099863 (2000-08-01), Gilis et al.
patent: 6132774 (2000-10-01), Ke et al.
patent: 6140321 (2000-10-01), Imai et al.
patent: 6140343 (2000-10-01), DeNinno et al.
patent: 6197786 (2001-03-01), DeNinno et al.
patent: 6245911 (2001-06-01), Imai et al.
patent: 6372760 (2002-04-01), Kato et al.
patent: 6710063 (2004-03-01), Chao
patent: 6723752 (2004-04-01), Sikorski et al.
patent: 6723753 (2004-04-01), Sikorski et al.
patent: 2003/0171377 (2003-09-01), Bigge et al.
patent: 2003/0225158 (2003-12-01), Auerbach et al.
patent: 2004/0157885 (2004-08-01), Bagley et al.
patent: 2004/0197398 (2004-10-01), Friesen et al.
patent: 3918364 (1990-12-01), None
patent: 0 252 476 (1988-01-01), None
patent: 0 475 627 (1992-03-01), None
patent: 08-143457 (1996-06-01), None
patent: WO 86/00307 (1986-01-01), None
patent: WO 94/00480 (1994-01-01), None
patent: WO 95/10513 (1995-04-01), None
patent: WO 96/10559 (1996-04-01), None
patent: WO 96/26948 (1996-09-01), None
patent: WO 96/39384 (1996-12-01), None
patent: WO 96/39385 (1996-12-01), None
patent: WO 96/40640 (1996-12-01), None
patent: WO 98/23593 (1998-06-01), None
patent: 9932434 (1999-01-01), None
patent: WO 99/12933 (1999-03-01), None
patent: 2005105079 (2005-11-01), None
Dutch Search Report No. 1030487 dated Aug. 22, 2006, 6 pages.
Ransac, Stephane, et al, “[10] Covalent Inactivation of Lipases”, Methods in Enzymology, vol. 286, pp. 190-231, 1997.
Grier, et al, “The Use of Dual Energy X-ray Absorptiometry in Animals”, Investigative Radiology, vol. 31(1), pp. 50-62, 1996.
Colowick, et al, “Methods in Enzymology”, Academic Press Inc., Publishers New York, vol. 1, 1955, pp. 149-159.
Peterson, Von Siegfried, “Neidermolekulare Umsetzungsprodkte aliphatischer Diisocyante”, Liebig's Annalen, 1949, 562, pp. 205-229.
Kitahara, et al, “Valilactone, an Inhibitor of Esterase, Produced By Actinomycetes”, J. of Antibiotics, 40(1), 1987, pp. 1647-1650.
Umezawa, et al, “Ebelactone, an Inhibitor of Esterase, Produced By Actinomycetes”, J. of Antibiotics, 33, 1980, pp. 1594-1596.
Wetterau, et al, “Absence of Microsomal Triglyceride Transfer Protein in Individuals with Abetalipoproteinemia”, Science, vol. 258, Nov. 6, 1992, pp. 999-1001.
Crook, et al, “Isolation and Characterization of Several Plasma Apolipoproteins of Common Marmoset Monkey”, Arteriosclerosis, vol. 10, No. 4, Jul./Aug. 1990, pp. 625-632.
McKenney, James M., “Pharmacologic Characteristics of Statins”, Clin. Cardiol., vol. 26 (Suppl. III), III-32-III-38 (2003).
The Lipid Research Clinics Coronary Primary Prevention Trial Results, J American Medical Assoc., 1984, vol. 251, No. 3, pp. 351-374.
Brown, et al, “Lowering Plasma Cholesterol By Raising LDL Receptors”, The New England Journal of Medicine, vol. 305, No. 9, pp. 515-517.
Berge, et al, “Pharmaceutical Salts”, J of Pharmaceutical Sciences, Jan. 1977, vol. 66, No. 1, pp. 1-19.
Ong, et al, “Assay of 3-Hydroxy-3-methylglutaryl CoA Reductase Activity Using Anionic-Exchange Column Chromatography”, Analyt. Biochem., 1991, vol. 196, pp. 211-214.
Stephan, et al, “Demonstration of potent lipid-lowering activity by a thyromimetic agent devoid of cardiovascular and thermogenic effects”, Atherosclerosis, vol. 126, 1996, pp. 53-63.
Dahlquist, et al, “Application of Secondary Alpha-Deuterium Kinetic Isotope Effects to Studies of Enzyme Catalysis. Glycoside Hydrolysis by Lysozyme and Beta-Glucosidase”, Biochemistry, vol. 8, No. 10, Oct. 1969, pp. 4214-4221.
Siegel, et al, “An Enzymatic Fluorometric Assay for Fructose”, Analyt. Biochem., vol. 280, 2000, pp. 329-331.
Blount, et al, “Synthesis of Some 2-Aminofurans from Cyanoacetone Enolate and Their Rearrangement to 3-Cyanopyrroles with Ammonia”, J. Org. Chem., vol. 43, No. 20, 1978, pp. 3821-3824.
Konoike, et al, “Practical Synthesis of Chiral Synthons for the Preparation of HMG-CoA Reductase Inhibitors”, J. Org. Chem., vol. 59, 1994, pp. 7849-7854. Abstract published Nov. 1, 1994.
Kesseler, et al,
Benson Gregg C.
Nardone Rona A.
Pfizer Inc.
Shameem Golam M
LandOfFree
Pyrazole-based HMG CoA reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazole-based HMG CoA reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazole-based HMG CoA reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4021223